Acumen Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Acumen Pharmaceuticals is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 5.00K	-	-	-	$ -1.00K
Gross Profit	$ 5.00K	-	-	-	$ -1.00K
EBIT	$ -15.92M	$ -12.96M	$ -11.61M	$ -11.31M	$ -14.26M
EBITDA	$ -17.65M	-	$ -11.86M	$ -11.59M	$ -14.30M
Net Income Common Stockholders	$ -16.50M	$ -12.96M	$ -11.61M	$ -11.31M	$ -12.87M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 243.52M	$ 215.43M	$ 144.88M	$ 140.41M	$ 177.60M
Total Assets	$ 310.13M	$ 286.37M	$ 177.41M	$ 187.71M	$ 196.59M
Total Debt	$ 31.05M	$ 2.00K	$ 29.00K	$ 67.00K	$ 105.00K
Net Debt	$ -212.47M	$ -215.43M	$ -144.85M	$ -140.34M	$ -177.50M
Total Liabilities	$ 43.15M	$ 6.10M	$ 8.53M	$ 8.26M	$ 7.81M
Stockholders Equity	$ 266.97M	$ 280.27M	$ 168.92M	$ 179.64M	$ 188.78M
Cash Flow	-
Free Cash Flow	$ -8.33M	-	$ -11.67M	$ -10.18M	$ -11.24M
Operating Cash Flow	$ -8.31M	$ -12.90M	$ -11.67M	$ -10.18M	$ -11.20M
Investing Cash Flow	$ -48.81M	$ -92.00M	$ 11.06M	$ -41.93M	$ -20.42M
Financing Cash Flow	$ 29.13M	$ 122.76M	$ -145.00K	-	$ 4.18M

Currency in USD

Acumen Pharmaceuticals Earnings and Revenue History

Income Statement >

Acumen Pharmaceuticals Debt to Assets

Balance Sheet >

Acumen Pharmaceuticals Cash Flow

Cash Flow >

Acumen Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing